B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.” Cancer Research 58, no. 9 (1998): 1860–1865.
15. Dumesic, Daniel A., and Rogerio A. Lobo. “Cancer risk and PCOS.” Steroids 78, no. 8 (2013): 782–785.
16. Haoula, Zeina, Maisa Salman, and William Atiomo. “Evaluating the association between endometrial cancer and polycystic ovary syndrome.” Human Reproduction 27, no. 5 (2012): 1327–1331; Chittenden, B.G., G. Fullerton, A. Maheshwari, and S. Bhattacharya. “Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review.” Reproductive Biomedicine Online 19, no. 3 (2009): 398–405.
17. Clavel-Chapelon, Françoise. “Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.” Cancer Causes & Control 13, no. 9 (2002): 831–838.
18. Chang, King-Jen, Tigris T.Y. Lee, Gustavo Linares-Cruz, Sabine Fournier and Bruno de Ligniéres. “Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo.” Fertility and Sterility 63, no. 4 (1995): 785–791; Prior, Jerilynn C. “Preventive Powers of Ovulation and Progesterone: Ovulation and Breast Health.” Accessed January 8, 2017. www.cemcor.ca/files/uploads/6_Ovulation_and_Breast_Health.pdf
19. Whelan, Elizabeth A., Dale P. Sandler, Jan L. Root, Ken R. Smith, and Clarice R. Weinberg. “Menstrual cycle patterns and risk of breast cancer.” American Journal of Epidemiology 140, no. 12 (1994): 1081–1090.
20. Seifert-Klauss, Vanadin, and Jerilynn C. Prior. “Progesterone and bone: actions promoting bone health in women.” Journal of Osteoporosis (2010): 1–18.
21. Hergenroeder, Albert C. “Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults.” The Journal of Pediatrics 126, no. 5 (1995): 683–689; Cann, Christopher E., Mary C. Martin, Harry K. Genant, and Robert B. Jaffe. “Decreased spinal mineral content in amenorrheic women.” JAMA 251, no. 5 (1984): 626–629; Chou, Sharon H., and Christos Mantzoros. “Bone metabolism in anorexia nervosa and hypothalamic amenorrhea.” Metabolism 80 (2018): 91–104.
22. Hart, Roger, and Dorota A. Doherty. “The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage.” The Journal of Clinical Endocrinology & Metabolism 100, no. 3 (2015): 911–919; Orio Jr., Francesco, Stefano Palomba, Letizia Spinelli, Teresa Cascella, Libuse Tauchmanovà, Fulvio Zullo, Gaetano Lombardi, and Annamaria Colao. “The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.” The Journal of Clinical Endocrinology & Metabolism 89, no. 8 (2004): 3696–3701.
23. Cheng, Wanli, Ontario D. Lau, and Nada A. Abumrad. “Two antiatherogenic effects of progesterone on human macrophages; inhibition of cholesteryl ester synthesis and block of its enhancement by glucocorticoids.” The Journal of Clinical Endocrinology & Metabolism 84, no. 1 (1999): 265–271; Prior, Jerilynn C. “Progesterone within ovulatory menstrual cycles needed for cardiovascular protection: an evidence-based hypothesis.” Journal of Restorative Medicine 3, no. 1 (2014): 85–103.
Глава 2
1. Groothuis, P.G., H.H.N.M. Dassen, A. Romano and C. Punyadeera. “Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human.” Human Reproduction Update 13, no. 4 (2007): 405–417.
2. Kumar, Nirmala S., Jennifer Richer, Gareth Owen, Elizabeth Litman, Kathryn B. Horwitz, and Kimberly K. Leslie. “Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.” Cancer Research 58, no. 9 (1998): 1860–1865.
3. Hilgers, Thomas W. (2010). The NaPro Technology Revolution: Unleashing the Power in a Woman’s Cycle. New York, NY: Beaufort Books, 331–335.
4. Там же, 332; Fehring, Richard J., Mary Schneider, and Kathleen Raviele. “Variability in the phases of the menstrual cycle.” Journal of Obstetric, Gynecologic, & Neonatal Nursing 35, no. 3 (2006): 376–377.
5. Fehring, Richard J., Mary Schneider, and Kathleen Raviele. “Variability in the phases of the menstrual cycle.” Journal of Obstetric, Gynecologic, & Neonatal Nursing 35, no. 3 (2006): 376–377.
6. Guttorm, Eigil. “Menstrual bleeding with intrauterine contraceptive devices.” Acta Obstetricia et Gynecologica Scandinavica 50, no. 1 (1971): 9–16; Dasharathy, Sonya S., Sunni L. Mumford, Anna Z. Pollack, Neil J. Perkins, Donald R. Mattison, Jean Wactawski-Wende, and Enrique F. Schisterman. “Menstrual bleeding patterns among regularly menstruating women.” American Journal of Epidemiology 175, no. 6 (2012): 536–545; Livingstone, Mark, and Ian S. Fraser. “Mechanisms of abnormal uterine bleeding.” Human Reproduction Update 8, no. 1 (2002): 60–67.
7. Fehring, Richard J., Mary Schneider, and Kathleen Raviele. “Variability in the phases of the menstrual cycle.” Journal of Obstetric, Gynecologic, & Neonatal Nursing 35, no. 3 (2006): 376–377.
8. Price, D.C., E.M. Forsyth, S.H. Cohn, and E.P. Cronkite. “The study of menstrual and other blood loss, and consequent iron deficiency, by Fe59 whole-body counting.” Canadian Medical Association Journal 90, no. 2 (1964): 51; Fraser, Ian S., H.O.D. Critchley, M.G. Munro, and M. Broder. “Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?” Human Reproduction 22, no. 3 (2007): 635–643; Dasharathy, Sonya S., Sunni L. Mumford, Anna Z. Pollack, Neil J. Perkins, Donald R. Mattison, Jean Wactawski-Wende, and Enrique F. Schisterman. “Menstrual bleeding patterns among regularly menstruating women.” American Journal of Epidemiology 175, no. 6 (2012): 536–545; Hallberg, Leif, Ann-Marie Hôgdahl, Lennart Nilsson, and Göran Rybo. “Menstrual blood loss – a population study.” Acta Obstetricia et Gynecologica Scandinavica 45, no. 3 (1966): 320–351; Hallberg, Leif, Ann-Marie Högdahl, Lennart Nilsson, and Göran Rybo. “Menstrual blood loss and iron deficiency.” Acta Medica Scandinavica 180, no. 5 (1966): 639–650.
9. Hallberg, Leif, and Lennart Nilsson. “Constancy of individual menstrual blood loss.” Acta Obstetricia et Gynecologica Scandinavica 43, no. 4 (1964): 352–359; Cheong, Revelita L., Miriam D. Kuizon, and Rosario T. Tajaon. “Menstrual blood loss and iron nutrition in Filipino women.” The Southeast Asian Journal of Tropical Medicine and Public Health 22, no. 4 (1991): 595–604; Dasharathy, Sonya S., Sunni L. Mumford, Anna Z. Pollack, Neil J. Perkins, Donald R. Mattison, Jean Wactawski-Wende, and Enrique F. Schisterman. “Menstrual bleeding patterns among regularly menstruating women.” American Journal of Epidemiology 175, no. 6 (2012): 536–545; Barer, Adelaide P., and W.M. Fowler. “The blood loss during normal menstruation.” American Journal of Obstetrics and Gynecology 31, no. 6 (1936): 979–986; Price, D.C., E.M. Forsyth, S.H. Cohn, and E.P. Cronkite. “The study of menstrual and other blood loss, and consequent iron deficiency, by Fe59 whole-body counting.” Canadian Medical Association Journal 90, no. 2 (1964):
